Companyartificial intelligencebiotechcompliancesecuritysynthetic biologyhealthcarebiosecuritybio aiindustrial bioyc
TwentyTwo
TwentyTwo is an AI infrastructure company focused on biosecurity [2]. Based in New York City [4], the company was accepted into Y Combinator's Summer 2025 batch [5] and remains active [6]. The company operates with a team of three people [7]. According to its Y Combinator profile, TwentyTwo addresses the dual-use implications of artificial intelligence in biology: while AI is accelerating the development of life-saving drugs and therapies, it simultaneously enables bad actors to create pandemic threats [3]. The company describes its mission as building defensive infrastructure to prevent the next pandemic [3].
About
- AI is making biology easy to engineer. Life-saving drugs and therapies are accelerating, but so is the ability for bad actors to create a pandemic. TwentyTwo is working on the defensive stack to prevent the next pandemic.[3]
- AI is making biology easy to engineer. Life-saving drugs and therapies are accelerating, but so is the ability for bad actors to create a pandemic. TwentyTwo is working on the defensive stack to prevent the next pandemic.[9]
Something wrong or missing? Send a correction. Fixed within 24 hours.